APOE and Alzheimer disease: Moreover, our study attempted to add new evidence for the preclinical stage of AD [12] and proved that the concentration of nEV Aβ42 is already increased in Aβ+ NCs, although its diagnostic efficacy was not marked (AUC with APOE genotype = 0.705).